BUZZ-嘉德药房因启动二次发行而下滑3月18日 - ** 嘉德药房服务公司GRDN.N在发起500万股二次发行后,股价在延时交易中下跌10%,至30.53美元。
** 长期护理药房服务公司称 (link) 某些股东将抛售 398 万股股票,公司将发行 102 万股股票
** GRDN 将使用其获得的净发行收益从某些现有持有人手中回购股份
** 联合账簿管理人:BofA、Jefferies 和 Raymond James
** 总部位于佐治亚州亚特兰大市的 GRDN 拥有 6,330 万股流通股
** 周三收盘时股价下跌 0.5%,报 33.91 美元,将年初至今的涨幅缩减至 13% 左右。
** 覆盖该股的 4 位分析师中,2 位给予 "强烈买入 "评级,2 位给予 "买入 "评级;根据 LSEG 的数据,中位 PT 值为 38 美元。
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
At the request of the copyright holder, you need to log in to view this content
LOGIN / SIGN UPDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.